GLYCIPHAGE VG 1 (Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg))

GLYCIPHAGE VG 1 is a combination medicine primarily used to help manage blood sugar levels in individuals with type 2 diabetes. By combining three active ingredients, this formulation works to improve the body’s ability to utilize insulin and control glucose levels more effectively. It supports patients in maintaining better overall health and metabolic balance.

The active ingredients in GLYCIPHAGE VG 1 include Glimepiride, Metformin, and Voglibose. Glimepiride helps stimulate the pancreas to produce more insulin, while Metformin reduces glucose production in the liver and enhances insulin sensitivity in the body. Voglibose works by slowing the absorption of carbohydrates from the intestines, which helps prevent spikes in blood sugar after meals. Together, these components work synergistically to aid in blood sugar management.

For best results, it is important to store this medicine in a cool, dry place, away from direct sunlight and moisture. Consistency in use is key to managing diabetes effectively. Patients should always follow their healthcare provider’s advice and maintain a balanced diet and regular physical activity.

Some common mild side effects may include digestive issues such as bloating or gas, low blood sugar symptoms like dizziness or sweating, and possible skin reactions. These effects are generally mild but should be monitored.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.